Loss-of-function analyses using RNA interference suggest that EpCAM expression is associated with increased invasion in breast cancer [4], and gain-of-function analyses in colorectal and lung cancers suggest that EpCAM expression is associated with decreased cancer invasion in these cancer types [29,30]. The gene discussed is EPCAM; the disease is breast carcinoma.